First Time Loading...
C

CSSC Science & Technology Co Ltd
SSE:600072

Watchlist Manager
CSSC Science & Technology Co Ltd
SSE:600072
Watchlist
Price: 15.72 CNY -1.69% Market Closed
Updated: May 15, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

48.5B
+538%
Assets
Growth Rates:
1 Year
+530%
3 Years
+357%
5 Years
+327%
7 Years
+2 130%
10 Years
+1 961%
37.6B
+954%
Liabilities
Growth Rates:
1 Year
+907%
3 Years
+449%
5 Years
+388%
7 Years
+3 456%
10 Years
+3 241%
11B
+171%
Equity
Growth Rates:
1 Year
+176%
3 Years
+189%
5 Years
+200%
7 Years
+879%
10 Years
+791%

Balance Sheet Decomposition
CSSC Science & Technology Co Ltd

48.5B
Assets
37.6B
Liabilities
48.5B
Assets
37.6B
Liabilities
Current Assets 30.7B
Cash & Short-Term Investments 6.6B
Receivables 14.1B
Other Current Assets 10B
Non-Current Assets 17.9B
Long-Term Investments 1.7B
PP&E 11B
Intangibles 787.3m
Other Non-Current Assets 4.3B
Current Liabilities 20.3B
Accounts Payable 9.4B
Accrued Liabilities 166.5m
Short-Term Debt 6.5B
Other Current Liabilities 4.2B
Non-Current Liabilities 17.3B
Long-Term Debt 15.4B
Other Non-Current Liabilities 1.9B

Balance Sheet
CSSC Science & Technology Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
220
376
1 617
2 438
1 350
1 050
2 332
1 336
1 211
702
Cash
0
0
0
0
0
0
0
0
1 211
702
Cash Equivalents
220
376
1 617
2 438
1 350
1 050
2 332
1 336
0
0
Total Receivables
428
513
1 749
2 038
1 817
2 154
1 717
3 017
1 782
2 506
Accounts Receivables
413
483
1 167
1 528
1 183
1 387
1 020
2 168
1 543
2 308
Other Receivables
15
30
582
510
634
767
697
849
238
198
Inventory
477
497
2 212
1 241
1 414
1 293
734
1 057
1 236
1 295
Other Current Assets
21
24
701
1 009
1 219
1 302
240
1 291
1 440
795
Total Current Assets
1 146
1 410
6 279
6 727
5 801
5 798
5 024
6 701
5 669
5 297
PP&E Net
761
743
822
1 239
1 266
1 356
1 420
1 107
889
808
PP&E Gross
761
743
822
1 239
1 266
1 356
1 420
1 107
889
808
Accumulated Depreciation
373
405
613
317
314
337
312
344
246
265
Intangible Assets
75
87
149
174
111
107
85
83
57
55
Note Receivable
0
0
691
2 698
3 422
2 926
2 210
375
406
328
Long-Term Investments
152
143
339
303
317
313
415
745
799
993
Other Long-Term Assets
13
12
24
36
28
27
42
39
34
47
Total Assets
2 147
N/A
2 394
+12%
8 305
+247%
11 178
+35%
10 945
-2%
10 528
-4%
9 196
-13%
9 052
-2%
7 854
-13%
7 529
-4%
Liabilities
Accounts Payable
437
337
960
1 447
1 208
831
1 248
1 607
1 224
1 432
Accrued Liabilities
40
17
45
83
46
26
25
22
107
99
Short-Term Debt
103
319
1 824
1 610
2 544
2 069
1 151
424
90
341
Current Portion of Long-Term Debt
160
0
0
400
0
950
0
500
811
27
Other Current Liabilities
97
416
683
1 094
594
461
586
874
1 040
801
Total Current Liabilities
837
1 089
3 512
4 635
4 392
4 337
3 010
3 428
3 272
2 701
Long-Term Debt
100
100
2 280
2 440
2 210
1 260
2 113
1 282
213
398
Deferred Income Tax
3
0
1
3
4
4
12
14
10
9
Minority Interest
63
64
417
409
410
496
115
329
329
328
Other Liabilities
5
5
58
67
276
712
63
76
74
72
Total Liabilities
1 007
N/A
1 258
+25%
6 268
+398%
7 553
+21%
7 292
-3%
6 809
-7%
5 313
-22%
5 128
-3%
3 898
-24%
3 508
-10%
Equity
Common Stock
478
478
478
736
736
736
736
736
736
736
Retained Earnings
242
252
517
450
485
549
654
708
752
817
Additional Paid In Capital
406
406
1 048
2 439
2 439
2 440
2 460
2 444
2 444
2 444
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
42
41
Other Equity
14
0
7
0
7
7
33
35
19
17
Total Equity
1 140
N/A
1 136
0%
2 036
+79%
3 625
+78%
3 653
+1%
3 718
+2%
3 883
+4%
3 924
+1%
3 956
+1%
4 021
+2%
Total Liabilities & Equity
2 147
N/A
2 394
+12%
8 305
+247%
11 178
+35%
10 945
-2%
10 528
-4%
9 196
-13%
9 052
-2%
7 854
-13%
7 529
-4%
Shares Outstanding
Common Shares Outstanding
478
478
478
736
736
736
736
736
736
736

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.